Frank A. D’Amelio
Independent Director
Former Executive Vice President and Chief Financial Officer, Pfizer Inc.
Director since
July 2012
Committees
Audit; Human Resources (Chair)
Other Current Public Company Directorships
Humana Inc. (since September 2003)
Hewlett Packard Enterprise (since January 2023)
Viatris Inc. (since May 2025)
Mr. D'Amelio provides unparalleled institutional knowledge of Zoetis, having been instrumental in conceptualizing and establishing the Company as a standalone entity from Pfizer. He brings exceptional financial acumen and extensive M&A expertise from his role as Executive Vice President and Chief Financial Officer of Pfizer, having led numerous acquisitions, partnerships and divestitures, including the transformative divestiture of the animal health business that created Zoetis. His pragmatism and deep operational experience overseeing global supply chains, information technology and major business transformations, combined with his extensive public company board service, contributes an invaluable perspective to the Board.
Skills and Qualifications
Animal Health
Consumer Products
Digital and Technology
Global Businesses
Human Capital Management
Life Sciences
Manufacturing and Supply
Mergers and Acquisitions
Other Public Company Board Member
Public Company CFO; or Finance and Accounting
As the former Executive Vice President and Chief Financial Officer of Pfizer Inc., as well as several other senior leadership roles, was responsible for Business Operations and Global Supply divisions, and finance, operations and strategic initiatives.
Led acquisitions, partnerships and divestitures valued at nearly $200 billion during tenure at Pfizer, including transformative transactions such as the acquisition of Wyeth and the divestiture of the animal health business that created Zoetis, bringing unparalleled M&A expertise and a deep understanding of the company’s history and strategic value proposition.
Extensive operational expertise overseeing global supply chains, information technology functions and major business transformations, including large-scale technology implementations of enterprise risk management programs, with proven ability to provide pragmatic guidance on appropriate budgeting and transformative impact of major projects.
Significant public company board experience, currently serving on the boards of directors of Humana Inc. (since 2003), Hewlett Packard Enterprise (since 2023) and Viatris Inc. (since May 2025), with previous service on the boards of Catalent Inc. and the National Advisory Board of JPMorgan Chase & Co., bringing extensive governance perspective.
Career Highlights
Pfizer Inc. (NYSE: PFE) – a global pharmaceutical company
- Executive Vice President and Chief Financial Officer (2020-2022)
- Executive Vice President, Global Supply and Business Operations (2020-2021)
- Executive Vice President, Business Operations and Global Supply and Chief Financial Officer (2018-2020)
- Executive Vice President, Business Operations and Chief Financial Officer (2010-2018)
- Senior Vice President and Chief Financial Officer (2007-2010)
Alcatel-Lucent, S.A. – a global telecommunications equipment company
- Senior Executive Vice President of Integration and Chief Administrative Officer (2006- 2007)
Lucent Technologies – a telecommunications equipment company
- Chief Operating Officer (2005-2007)
- Executive Vice President, Administration and Chief Financial Officer (2001-2006)
Education
- Bachelor’s degree in Accounting from St. Peter’s College
- Master of Business Administration in Finance from St. John’s University